Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Influenza Vaccine Revaccination in Ambulatory Elderly Subjects

ClinicalTrials.gov ID: NCT00775450

Public ClinicalTrials.gov record NCT00775450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 2:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Immunogenicity of Revaccination With Influenza Vaccine in Ambulatory Elderly Subjects Previously Vaccinated With Fluzone ID, Fluzone HD, and Fluzone® IM

Study identification

NCT ID
NCT00775450
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Industry
Enrollment
807 participants

Conditions and interventions

Interventions

  • Influenza Virus Vaccine USP Trivalent Types A and B Biological

Biological

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2008
Primary completion
May 31, 2009
Completion
Jun 30, 2009
Last update posted
Dec 30, 2013

2008 – 2009

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Not listed Hoover Alabama 35216
Not listed Mobile Alabama 36608
Not listed Chandler Arizona 85224
Not listed Mesa Arizona 85213
Not listed Phoenix Arizona 85014
Not listed Tucson Arizona 85710
Not listed Fountain Valley California 92708
Not listed San Diego California 92103
Not listed Milford Connecticut 06460
Not listed Pembroke Pines Florida 33024
Not listed Pinellas Park Florida 33781
Not listed Chicago Illinois 60610
Not listed Wichita Kansas 67207
Not listed Kansas City Missouri 64114
Not listed Springfield Missouri 65802
Not listed St Louis Missouri 63110
Not listed Cary North Carolina 27518
Not listed Raleigh North Carolina 27609
Not listed Cincinnati Ohio 45249
Not listed Bensalem Pennsylvania 19020
Not listed Warwick Rhode Island 02886
Not listed Mt. Pleasant South Carolina 29464
Not listed Fort Worth Texas 76107
Not listed Galveston Texas 77555
Not listed Salt Lake City Utah 84109
Not listed Salt Lake City Utah 84121
Not listed West Jordan Utah 84088
Not listed Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00775450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 30, 2013 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00775450 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →